IMDX
Insight Molecular·NASDAQ
--
--(--)
--
--(--)
IMDX fundamentals
Insight Molecular (IMDX) Revenue Breakdown: Q3 2025 Business & Regional Performance
Insight Molecular (IMDX) reported total revenue of 260.00K USD in Q3 2025, with its core business segment Laboratory Developed Test Services contributing 100.00%. Regionally, United States remained the largest market, accounting for 100.00% of total revenue. Explore Insight Molecular's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
Insight Molecular (IMDX) reported total revenue of 260.00K USD in Q3 2025, with its core business segment Laboratory Developed Test Services contributing 100.00%. Regionally, United States remained the largest market, accounting for 100.00% of total revenue. Explore Insight Molecular's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
What is the market's earnings forecast for Insight Molecular next quarter?What is Insight Molecular's latest dividend and current dividend yield?What guidance did Insight Molecular's management provide for the next earnings period?What were the key takeaways from Insight Molecular’s earnings call?Did Insight Molecular beat or miss consensus estimates last quarter?What factors drove the changes in Insight Molecular's revenue and profit?What is the revenue and EPS growth rate for Insight Molecular year over year?What were the key takeaways from Insight Molecular's earnings call?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
